The CHD3 gene gives instructions for a protein that helps control when other genes are active, especially during early brain development. This gene plays an important role in how nerve cells grow and how the brain supports speech, learning, and muscle tone. A harmful variant in the CHD3 gene can cause Snijders Blok-Campeau syndrome, a condition often linked with delayed speech, learning differences, low muscle tone, and recognizable facial features. Effects can vary from person to person.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage processes throughout the body. Some provide the directions for building proteins, which do much of the work inside cells. Others mainly help regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
CHD3Gene function
What if the gene works
The CHD3 gene helps cells organize DNA and switch other genes on or off at the right time. This supports normal growth and brain development.
Risk
What if the gene does not work
Variants in the CHD3 gene can cause a neurodevelopmental condition with delayed speech and motor milestones, learning difficulties, and low muscle tone. Milder and more severe variants can influence how early features appear and how pronounced they are.
Treatment
What does that mean for your treatment
No CHD3-specific treatment or management approach is currently established; treatment is guided by each person’s symptoms and day to day needs rather than by the variant itself. The CHD3 gene is also being studied in cancer research, but this has not led to a gene directed treatment for inherited CHD3 variants.
Conditions associated with CHD3
Gene function
What if the gene works
Your cells need the CHD3 gene to manage how tightly DNA is packed and which instructions are easiest to read. Understanding what the CHD3 gene does helps explain how cells use some genes, keep others quieter, and stay organized from day to day. Its protein works as part of a larger protein group that helps control access to DNA.
The CHD3 gene uses energy to reposition DNA around spool-like proteins. This changes how open or compact a stretch of DNA is, so cells can control access to genetic instructions.
Its protein helps cells fine tune gene activity instead of leaving all genes equally active. This keeps the right instructions more active and others quieter at the right time.
Its protein works within the NuRD complex (a protein group that reshapes DNA packaging and adjusts gene activity). Together, these proteins help cells keep their instruction manual orderly and responsive.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants in the CHD3 gene affect protein function often comes down to changes in shape, stability, or energy use, which may weaken how the protein adjusts DNA packing inside cells. Some variants partly reduce this effect, while more disruptive variants can leave very little working protein or disturb the larger protein group it joins. In a CHD3-related neurodevelopmental condition, stronger functional disruption often goes with earlier or broader developmental differences, although there is overlap.
How variants are linked to conditions
Pathogenic variants in the CHD3 gene cause a CHD3-related neurodevelopmental condition, often called Snijders Blok-Campeau syndrome. People with this diagnosis commonly have developmental delay, speech and language difficulties, and learning differences, and some also have low muscle tone or autism features. Features vary widely from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a common, normal feature of human biology across the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant connected with a condition signals a possible association rather than a certain diagnosis, particularly when several genes and environmental factors play a role. In other situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to CHD3. In most cases, risk depends mainly on whether a disease-causing CHD3 change is present, either as a new change in the child or one inherited in the family.
Inheritance of CHD3 variants
Variants in the CHD3 gene are usually inherited in an autosomal dominant pattern. This means a parent carrying a disease-causing CHD3 variant can pass it to a child with a 50% chance in each pregnancy. CHD3 inheritance also includes new, de novo variants, which arise for the first time in the child and are not inherited from either parent. Both sons and daughters can inherit or pass on a CHD3 variant.
What does my CHD3 result mean for my family?
For CHD3, the main known pattern is dominant, which means a close family member with the same variant can also have features linked to it, even if those features are milder. Parents, brothers, sisters, and children may sometimes choose to learn whether they carry the same change. Some CHD3 variants happen for the first time in one person and are not inherited from either parent, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CHD3 variants usually uses a blood or saliva sample. A lab reads the DNA code in the CHD3 gene to look for variants and may also check for missing or extra pieces of genetic material. Results can show whether a CHD3 variant helps explain a person's features or supports a diagnosis.
When should I consider getting a genetic test?
Genetic testing for CHD3 may be worth considering when a child has unexplained developmental delay, marked speech or language delay, learning difficulties, low muscle tone, or autism-like features, especially with a larger head size or similar family history. It can help confirm a CHD3-related condition and clarify the chance of it running in the family.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it reveals depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same drug at the same dose, yet one may get the intended benefit while another may notice less effect or more side effects because their bodies absorb, break down, or respond to the medicine differently. This kind of variation is common and helps explain why treatment response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the CHD3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines work or which treatments are best. Questions about medicines, side effects, or changes in your health are best discussed with your doctor or pharmacist.
History
The CHD3 gene entered medical research through studies of the Mi-2 proteins in the 1990s, when scientists were mapping genes linked to cell control and immune targets. Initially understood only through visible traits, later recognized as tied to a specific gene, CHD3 became part of a broader effort to sort out a family of closely related genes. From these first observations, research expanded steadily as CHD3 was placed within the NuRD group of genes studied in developmental biology. A major clinical milestone came in 2018, when harmful variants in the CHD3 gene were linked to a neurodevelopmental condition now called Snijders Blok-Campeau syndrome. Since then, published case reports have helped clarify the range of features seen in affected children and adults.